Personalis Inc PSNL:NASDAQ

Last Price$4.81NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/11/22

Today's Change+0.04(0.84%)
Bid (Size)$4.57 (4)
Ask (Size)$4.90 (2)
Day Low / High$4.71 - 5.30
Volume957.2 K
 

View Biotechnology IndustryPeer Comparison as of 08/11/2022

 

Personalis Inc ( NASDAQ )

Price: $4.81
Change: +0.04 (0.84%)
Volume: 957.2 K
4:00PM ET 8/11/2022
 
 

Co-Diagnostics Inc ( NASDAQ )

Price: $6.46
Change: -0.16 (2.42%)
Volume: 1.0 M
4:00PM ET 8/11/2022
 
 

Verastem Inc ( NASDAQ )

Price: $1.21
Change: -0.05 (3.97%)
Volume: 860.5 K
4:00PM ET 8/11/2022
 
 

AVITA Medical Inc ( NASDAQ )

Price: $7.89
Change: +0.10 (1.28%)
Volume: 130.0 K
4:00PM ET 8/11/2022
 
 

Epizyme Inc ( NASDAQ )

Price: $1.47
Change: -0.02 (1.34%)
Volume: 22.3 M
4:00PM ET 8/11/2022
 

Read more news Recent News

--Citigroup Lowers Personalis' Price Target to $8 From $14, Maintains Buy Rating
3:24PM ET 8/04/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--HC Wainwright Adjusts Personalis' Price Target to $26 From $30, Reiterates Buy Rating
6:58AM ET 8/04/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (PSNL) PERSONALIS Reports Q2 Revenue $18.2M
4:01PM ET 8/03/2022 MT Newswires

...

Personalis Secures New US Patent for Molecular Residual Disease Detection Technology
4:52AM ET 7/13/2022 MT Newswires

Personalis (PSNL) said Tuesday it has added another patent family to its intellectual property portfolio related to molecular residual disease. The new...

Company Profile

Business DescriptionPersonalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA. View company web site for more details
Address1330 O'Brien Drive
Menlo Park, California 94025
Phone+1.650.752.1300
Number of Employees139
President, Chief Executive Officer & DirectorJohn S. West
Chief Financial Officer & Senior Vice PresidentAaron Tachibana
Chief Medical Officer, SVP-Research & DevelopmentRichard O. Chen
Vice President-Immunology, Research & DevelopmentXavier Paliard

Company Highlights

Price Open$4.93
Previous Close$4.81
52 Week Range$3.13 - 23.04
Market Capitalization$220.9 M
Shares Outstanding45.9 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/03/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.08
Beta vs. S&P 500N/A
Revenue$37.8 M
Net Profit Margin-122.53%
Return on Equity-31.55%

Analyst Ratings as of 07/14/2022

Buy
5
Overweight
0
Hold
2
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset